Prospector Partners LLC Abbott Laboratories Transaction History

Prospector Partners LLC

  • $861 Million
  • Q2 2024

A detailed history of Prospector Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Prospector Partners LLC holds 179,195 shares of ABT stock, worth $21.1 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares
179,195
Previous 174,225 2.85%
Holding current value
$21.1 Million
Previous $19.8 Million 5.97%
% of portfolio
2.16%
Previous 2.26%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$100.73 - $112.44 $500,628 - $558,826
4,970 Added 2.85%
179,195 $18.6 Million
Q1 2024

May 09, 2024
BUY
$109.52 - $120.96 $390,986 - $431,827
3,570 Added 2.09%
174,225 $19.8 Million
Q4 2023

Feb 09, 2024
BUY
$90.19 - $110.4 $7.81 Million - $9.56 Million
86,605 Added 103.04%
170,655 $18.8 Million
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $19,106 - $22,924
200 Added 0.24%
84,050 $8.14 Million
Q2 2023

Aug 10, 2023
BUY
$100.78 - $112.29 $977,566 - $1.09 Million
9,700 Added 13.08%
83,850 $9.14 Million
Q1 2023

May 08, 2023
BUY
$96.86 - $114.01 $4.58 Million - $5.39 Million
47,290 Added 176.06%
74,150 $7.51 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $181,174 - $218,981
-1,775 Reduced 6.2%
26,860 $2.92 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $786,738 - $959,376
-6,900 Reduced 19.42%
28,635 $3.39 Million
Q4 2021

Feb 11, 2022
SELL
$115.53 - $141.46 $173,295 - $212,190
-1,500 Reduced 4.05%
35,535 $5 Million
Q3 2021

Nov 10, 2021
SELL
$116.66 - $129.06 $670,795 - $742,095
-5,750 Reduced 13.44%
37,035 $4.38 Million
Q2 2021

Aug 11, 2021
SELL
$105.79 - $124.53 $79,342 - $93,397
-750 Reduced 1.72%
42,785 $4.96 Million
Q1 2021

May 13, 2021
SELL
$108.84 - $128.23 $179,586 - $211,579
-1,650 Reduced 3.65%
43,535 $5.22 Million
Q4 2020

Feb 11, 2021
SELL
$105.0 - $114.42 $194,250 - $211,677
-1,850 Reduced 3.93%
45,185 $4.95 Million
Q3 2020

Nov 13, 2020
SELL
$91.64 - $111.29 $1.98 Million - $2.41 Million
-21,625 Reduced 31.5%
47,035 $5.12 Million
Q2 2020

Aug 14, 2020
SELL
$76.57 - $98.0 $1.58 Million - $2.02 Million
-20,600 Reduced 23.08%
68,660 $6.28 Million
Q1 2020

May 13, 2020
SELL
$62.82 - $91.86 $103,024 - $150,650
-1,640 Reduced 1.8%
89,260 $7.04 Million
Q4 2019

Feb 13, 2020
BUY
$78.51 - $87.4 $70,659 - $78,660
900 Added 1.0%
90,900 $7.9 Million
Q3 2019

Nov 14, 2019
SELL
$81.84 - $88.74 $343,728 - $372,708
-4,200 Reduced 4.46%
90,000 $7.53 Million
Q2 2019

Aug 14, 2019
BUY
$72.88 - $85.0 $14,576 - $17,000
200 Added 0.21%
94,200 $7.92 Million
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $1.06 Million - $1.28 Million
-16,000 Reduced 14.55%
94,000 $7.51 Million
Q4 2018

Feb 14, 2019
SELL
$65.56 - $74.27 $157,344 - $178,248
-2,400 Reduced 2.14%
110,000 $7.96 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $97,296 - $117,376
1,600 Added 1.44%
112,400 $8.25 Million
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $46,056 - $50,832
-800 Reduced 0.72%
110,800 $6.76 Million
Q1 2018

May 15, 2018
SELL
$56.27 - $63.62 $118,167 - $133,602
-2,100 Reduced 1.85%
111,600 $6.69 Million
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $730,048 - $781,592
-13,600 Reduced 10.68%
113,700 $6.49 Million
Q3 2017

Nov 14, 2017
SELL
$48.06 - $53.64 $100,926 - $112,644
-2,100 Reduced 1.62%
127,300 $6.79 Million
Q2 2017

Aug 14, 2017
BUY
N/A
129,400
129,400 $6.29 Million

Others Institutions Holding ABT

# of Institutions
3,173
Shares Held
1.33B
Call Options Held
8.62M
Put Options Held
7.18M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Prospector Partners LLC Portfolio

Follow Prospector Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospector Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email